1. Absence of favourable changes in circulating levels of interleukin-16 or β-chemokine concentration following structured intermittent interruption treatment of chronic human immunodeficiency virus infection 
M. Montes de Oca Arjona, R. Pérez Cano, M.J. Orozco, A. Martín Aspas, F. Guerrero, C. Fernández Gutiérrez del Álamo, J.A. Girón- González 
Clinical Microbiology and Infection 
Volume 11, Issue 1, Pages (January 2005)
DOI: /j x
Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions

2. Fig. 1
Serum concentrations of interleukin (IL)-16, monocyte inhibitory protein-1β (MIP-1β), RANTES (‘regulated upon activation, normal T-cell expressed and presumably secreted') and monocyte chemotactic protein-1 (MCP-1) in patients with chronic human immunodeficiency virus infection, after three cycles of structured intermittent interruption of highly active anti-retroviral treatment (8 weeks on/4 weeks off).
Clinical Microbiology and Infection  , 57-62DOI: ( /j x)
Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions